Ampio Pharmaceuticals, Inc. Class Action Lawsuit - AMPE

Company
Ampio Pharmaceuticals, Inc. (NYSE: AMPE)
Lead Plaintiff Deadline
October 17, 2022 (Expired)
Class Definition
common stock between December 29, 2020 and August 3, 2022

Expired

Lead Plaintiff Deadline

Oct 17, 2022

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines

WhatsApp

Scan the QR code or click the button to join

Join on WhatsApp

Get Updates by Email

Required Field

Required Field

Required Field

No Spam, opt-out anytime, alert list is free

Allegations

(i) defendants had inflated the Company's true ability to successfully file a Biologics License Application ("BLA") for Ampion; (ii) defendants had inflated the results of the AP-013 study and the timing of unblinding the data from the AP-013 study; and (iii) as a result of the foregoing, defendants' statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Eligibility

In order to be eligible to join the AMPE class action lawsuit, you must have incurred a loss on shares of Ampio purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Ampio during the relevant time frame, you have until October 17, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

TOP